| A population-based study of genes previously implicated in breast cancer C Hu, SN Hart, R Gnanaolivu, H Huang, KY Lee, J Na, C Gao, J Lilyquist, ... New England Journal of Medicine 384 (5), 440-451, 2021 | 604 | 2021 |
| Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer C Hu, SN Hart, EC Polley, R Gnanaolivu, H Shimelis, KY Lee, J Lilyquist, ... Jama 319 (23), 2401-2409, 2018 | 504 | 2018 |
| Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer S Yadav, C Hu, SN Hart, N Boddicker, EC Polley, J Na, R Gnanaolivu, ... Journal of Clinical Oncology 38 (13), 1409, 2020 | 84 | 2020 |
| Contribution of germline predisposition gene mutations to breast cancer risk in African American women JR Palmer, EC Polley, C Hu, EM John, C Haiman, SN Hart, M Gaudet, ... JNCI: Journal of the National Cancer Institute 112 (12), 1213-1221, 2020 | 66 | 2020 |
| Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score C Gao, EC Polley, SN Hart, H Huang, C Hu, R Gnanaolivu, J Lilyquist, ... Journal of Clinical Oncology 39 (23), 2564, 2021 | 59 | 2021 |
| Mutations in BRCA1/2 and other panel genes in patients with metastatic breast cancer—Association with patient and disease characteristics and effect on prognosis PA Fasching, S Yadav, C Hu, M Wunderle, L Häberle, SN Hart, M Rübner, ... Journal of Clinical Oncology 39 (15), 1619, 2021 | 55 | 2021 |
| Contralateral breast cancer risk among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2 S Yadav, NJ Boddicker, J Na, EC Polley, C Hu, SN Hart, RD Gnanaolivu, ... Journal of Clinical Oncology 41 (9), 1703-1713, 2023 | 53 | 2023 |
| Cancer susceptibility gene mutations in type I and II endometrial cancer B Long, J Lilyquist, A Weaver, C Hu, R Gnanaolivu, KY Lee, SN Hart, ... Gynecologic oncology 152 (1), 20-25, 2019 | 43 | 2019 |
| Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance ME Richardson, C Hu, KY Lee, H LaDuca, K Fulk, KM Durda, ... The American Journal of Human Genetics 108 (3), 458-468, 2021 | 41 | 2021 |
| Pathogenic variants in cancer predisposition genes and prostate cancer risk in men of African ancestry M Matejcic, Y Patel, J Lilyquist, C Hu, KY Lee, RD Gnanaolivu, SN Hart, ... JCO precision oncology 4, 32-43, 2020 | 38 | 2020 |
| Risk of late-onset breast cancer in genetically predisposed women NJ Boddicker, C Hu, JN Weitzel, P Kraft, KL Nathanson, DE Goldgar, J Na, ... Journal of Clinical Oncology 39 (31), 3430, 2021 | 28 | 2021 |
| Effect of germline mutations in homologous recombination repair genes on overall survival of patients with pancreatic adenocarcinoma S Yadav, PM Kasi, WR Bamlet, TP Ho, EC Polley, C Hu, SN Hart, ... Clinical Cancer Research 26 (24), 6505-6512, 2020 | 28 | 2020 |
| Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast S Yadav, C Hu, KL Nathanson, JN Weitzel, DE Goldgar, P Kraft, ... Journal of Clinical Oncology 39 (35), 3918, 2021 | 25 | 2021 |
| Contribution of inherited DNA-repair gene mutations to hormone-sensitive and castrate-resistant metastatic prostate cancer and implications for clinical outcome S Yadav, SN Hart, C Hu, D Hillman, KY Lee, R Gnanaolivu, J Na, ... JCO Precision Oncology 3, 1-12, 2019 | 24 | 2019 |
| Risk of different cancers among first-degree relatives of pancreatic cancer patients: influence of probands’ susceptibility gene mutation status SO Antwi, SE Fagan, KG Chaffee, WR Bamlet, C Hu, EC Polley, SN Hart, ... JNCI: Journal of the National Cancer Institute 111 (3), 264-271, 2019 | 15 | 2019 |
| Age-related breast cancer risk estimates for the general population based on sequencing of cancer predisposition genes in 19,228 breast cancer patients and 20,211 matched … FJ Couch, C Hu, SN Hart, RD Gnanaolivu, J Lilyquist, KY Lee, C Gao, ... CANCER RESEARCH 79 (4), 2019 | 9 | 2019 |
| Functional and clinical characterization of variants of uncertain significance identifies a hotspot for inactivating missense variants in RAD51C C Hu, AB Nagaraj, H Shimelis, G Montalban, KY Lee, H Huang, ... Cancer research 83 (15), 2557-2571, 2023 | 3 | 2023 |
| Abstract GS2-01: Age-related breast cancer risk estimates for the general population based on sequencing of cancer predisposition genes in 19,228 breast cancer patients and 20 … FJ Couch, C Hu, SN Hart, RD Gnanaolivu, J Lilyquist, KY Lee, C Gao, ... Cancer Research 79 (4_Supplement), GS2-01-GS2-01, 2019 | 3 | 2019 |
| Abstract GS4-04: Population-based Estimates of contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2 S Yadav, NJ Boddicker, J Na, EC Polley, C Hu, SN Hart, RD Gnanaolivu, ... Cancer Research 83 (5_Supplement), GS4-04-GS4-04, 2023 | 2 | 2023 |
| The CARRIERS consortium: Establishing refined breast cancer risk estimates in known predisposition genes J Lilyquist, P Kraft, SN Hart, EJ Hallberg, C Hu, R Moore, R Gnanaolivu, ... Cancer Research 76 (14_Supplement), 810-810, 2016 | 2 | 2016 |
